Prof. Maoyi Xu | Thoracic Neoplasms | Best Researcher Award

Prof. Maoyi Xu | Thoracic Neoplasms | Best Researcher Award

The Affiliated Hospital of Jiaxing University | China

AUTHOR PROFILE

Scopus

🏫 EARLY ACADEMIC PURSUITS

Maoyi Xu began his academic journey with a Bachelor of Medicine in Clinical Medicine at Jiaxing University (2009–2014). During these formative years, Xu developed a strong foundation in medical sciences and clinical applications, showcasing a keen interest in oncology. This passion led him to pursue advanced education, obtaining a Master of Medicine in Oncology from Dalian Medical University, China, in 2017. His graduate studies were characterized by rigorous research and hands-on training, laying the groundwork for his future career in oncology.

💼 PROFESSIONAL ENDEAVORS

Maoyi Xu’s professional career began with a pivotal role at the Department of Radiotherapy Oncology, Zhuji People’s Hospital of Zhejiang Province (2017–2019), affiliated with Wenzhou Medical University. Here, he honed his skills in radiotherapy and gained invaluable experience treating cancer patients.
In 2019, Xu transitioned to the Department of Oncology at the First Affiliated Hospital of Jiaxing University, where he continues to work. His role involves comprehensive patient care, cutting-edge research, and contributions to the hospital’s oncology department’s growth.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON THORACIC NEOPLASMS

Xu has focused his research on innovative cancer treatment strategies, particularly in radiotherapy and targeted oncology treatments. He is committed to improving patient outcomes by integrating the latest advancements in oncology into clinical practice. Xu’s research bridges the gap between theory and application, enhancing therapeutic methodologies to benefit patients.

🌟 IMPACT AND INFLUENCE

Through his work, Xu has positively influenced oncology practices within Zhejiang Province and beyond. His contributions have led to advancements in radiotherapy techniques and improved patient care protocols. Xu is also a mentor to young professionals, fostering a culture of learning and collaboration.

📊 ACADEMIC CITATIONS

Although Xu’s academic citations are in development, his publications have started to gain recognition in medical circles. His research papers focus on innovative radiotherapy approaches and patient-centered care strategies. These contributions are adding value to the field of oncology.

🏅 LEGACY AND FUTURE CONTRIBUTIONS

Maoyi Xu is poised to leave a lasting legacy as a dedicated oncologist and researcher. He envisions a future where his contributions will significantly impact cancer treatment practices and policies, particularly in China. Xu aims to pioneer new research initiatives, foster interdisciplinary collaboration, and improve cancer care at both the local and global levels.

OTHER IMPORTANT TOPICS

🌐 COMMUNITY ENGAGEMENT

Xu actively participates in health awareness programs, aiming to educate the public about early cancer detection and prevention.

📚 CONTINUOUS LEARNING

A proponent of lifelong learning, Xu frequently attends conferences and workshops, staying updated on the latest developments in oncology.

🧬 INNOVATIVE PRACTICES

Xu is exploring personalized medicine and genetic research in oncology, positioning himself at the forefront of emerging trends.

📝 CONCLUSION

Maoyi Xu’s journey from an aspiring medical student to a dedicated oncologist and researcher exemplifies a commitment to excellence and innovation in the field of oncology. His academic pursuits laid a solid foundation for his professional growth, while his clinical and research contributions continue to impact cancer treatment and patient care.

 

📊🔬NOTABLE PUBLICATION:
  • The combination of decitabine and aspirin inhibits tumor growth and metastasis in non-small cell lung cancer
    • Authors: Xu, M., Song, B., Yang, X., Li, N.
    • Journal: Journal of International Medical Research
    • Year: 2022

 

  • Exosomal miR-122-3p represses the growth and metastasis of MCF-7/ADR cells by targeting GRK4-mediated activation of the Wnt/β-catenin pathway
    • Authors: Song, B., Hou, G., Xu, M., Chen, M.
    • Journal: Cellular Signalling
    • Year: 2024

 

  • Zoledronic acid inhibits the bone metastasis of breast cancer by repressing exosome-loaded DKK1
    • Authors: Song, B.B., Xu, M.Y., Xu, X.F., Li, X., Chen, M.
    • Journal: Bangladesh Journal of Pharmacology
    • Year: 2022

 

  • Association between the Khorana risk score and all-cause mortality in Japanese patients with gastric and colorectal cancer: A retrospective cohort study
    • Authors: Zhang, Y.-F., Wang, G.-D., Huang, M.-G., Si, J., Xu, M.-Y.
    • Journal: World Journal of Gastrointestinal Oncology
    • Year: 2023

 

  • β-elemene inhibits radiation and hypoxia-induced macrophages infiltration via Prx-1/NF-κB/HIF-1α signaling pathway
    • Authors: Yu, X., Li, Z., Zhang, Y., Zou, K., Zou, L.
    • Journal: OncoTargets and Therapy
    • Year: 2019

Prof Dr.Sheeren Mohammed Khaled – Cancer Science – Best Researcher Award

Prof Dr.Sheeren Mohammed Khaled - Cancer Science - Best Researcher Award

King Abdullah Medical City - Saudi Arabia

AUTHOR PROFILE

Scopus

Orcid

EARLY ACADEMIC PURSUITS:

Dr. Sheeren Mohammed Khaled began her academic journey with a Bachelor of Medicine and Surgery (M.B., B.Ch.) from Benha University, Faculty of Medicine, graduating with excellence in December 2005. Following this, she pursued her Master's degree in Cardiology at Benha University, graduating with a very good grade in September 2010. Dr. Khaled continued her academic endeavors, earning her MD degree in Cardiology from Benha University in May 2014.

PROFESSIONAL ENDEAVORS:

Dr. Khaled's professional journey reflects a rich and diverse experience in the field of Cardiology: Consultant Cardiology at King Abdullah Medical City (KAMC), Associate Professor of Cardiology at Benha University, Lecturer of Cardiology at Benha University Hospital, Associate Consultant Cardiology at KAMC, Cardiology Specialist at Alzahra Hospital (Saudi Arabia), Assistant Lecturer at Benha University Hospital.

IMPACT AND INFLUENCE ON CANCER SCIENCE

Dr. Sheeren Mohammed Khaled has made significant contributions to the field of cancer science through her roles as a clinician, educator, and researcher. Her commitment to teaching, clinical excellence, and research activities has had a positive impact on both students and colleagues.

ACADEMIC CITATIONS:

Dr. Khaled's academic citations are reflective of her contributions to research studies, the supervision of theses, and active involvement in various scientific committees.

LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Sheeren Mohammed Khaled's legacy lies in her dedication to advancing cardiology education, patient care, and research. Her future contributions are anticipated to further enrich the field through continued excellence in teaching, clinical practice, and impactful research initiatives.

NOTABLE PUBLICATIONS

Myocardial recovery after percutaneous coronary intervention in coronary artery disease patients with impaired systolic function- predictive utility of global longitudinal strain.2022

Severe Left Ventricular Dysfunction Earlier after Acute Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention: Predictors and In-Hospital Outcome– A Middle Eastern Tertiary Center Experience.2023

Cardiogenic Shock Among Patients with Acute ST-Segment Elevation Myocardial Infarction in a Middle Eastern Country: A Single-Center Experience.2023